SEC Form 4 · accession 0001179110-17-015361
HEALTHEQUITY, INC. · HQY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Delano Ladd
Officer — EVP, Counsel & Secretary
Period of report
Dec 12, 2017
Accepted (ET)
Dec 14, 2017 · 4:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001428336
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 12, 2017 | M | 12,655 | $24.36 | A | 16,692 | D | |
| Common Stock | Dec 12, 2017 | M | 13,750 | $30.57 | A | 30,442 | D | |
| Common Stock | Dec 12, 2017 | S | 26,405 | $43.3211 | D | 4,037 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $24.36 | Dec 12, 2017 | M | 12,655 | D | — | Mar 23, 2026 | Common Stock | 12,655 | 41,250 | D |
| Stock Option (right to buy)F3 | $30.57 | Dec 12, 2017 | M | 13,750 | D | — | Aug 24, 2026 | Common Stock | 13,750 | 41,250 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.05 to $43.66, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
- F2The option becomes exercisable in three equal annual installments of 13,750 shares on April 1, 2018, 2019, and 2020.
- F3The option becomes exercisable in three equal annual installments of 13,750 shares on August 24, 2018, 2019, and 2020.